Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Queensland Health
Boehringer Ingelheim

Generated: September 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,939,519

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,939,519 protect, and when does it expire?

Patent 7,939,519 protects MAYZENT and is included in one NDA.

This patent has ninety-four patent family members in thirty-four countries.

Summary for Patent: 7,939,519
Title:Immunosuppresant compounds and compositions
Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
Inventor(s): Pan; Shifeng (San Diego, CA), Gao; Wenqi (San Diego, CA), Gray; Nathanael S (San Diego, CA), Mi; Yuan (San Diego, CA), Fan; Yi (Poway, CA)
Assignee: Novartis AG (Basel, CH)
Application Number:12/024,992
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 7,939,519

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-001 Mar 26, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-002 Mar 26, 2019 RX Yes Yes   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.